BioInvent developes Anti-TNFR2 programme for cancer treatment

Drug Discovery |  News | 0 Comment | 21 Mar, 2019

BioInvent International AB, focused on the discovery and development of novel and first-in-class immuno-regulatory antibody-based medicines generated by its proprietary platforms, disclosed...Read more

EC approves Roche’s MabThera for a rare autoimmune disease

Drug Discovery |  News | 0 Comment | 19 Mar, 2019

Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with moderate to severe pemphigus vulgaris (PV), a rare condition characteris...Read more

Ono Pharma, twoXAR announce drug discovery research collaboration

Drug Discovery |  News | 0 Comment | 19 Mar, 2019

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based artificial intelligence (AI)-driven biopharmaceutical company, have an...Read more

Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma

Drug Discovery |  News | 0 Comment | 14 Mar, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) se...Read more

FDA approves new nasal spray for treatment-resistant depression

Drug Discovery |  News | 0 Comment | 06 Mar, 2019

The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried ot...Read more

Glenmark announces presentation of New Subtype Analysis of GBR 830

Drug Discovery |  News | 0 Comment | 04 Mar, 2019

Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase 2a, proof-of-concept study of GBR 830 at the American Academy of Dermatology (AAD) An...Read more

USFDA accepts Merck and Pfizer’s sBLA for Renal Cancer drug

Drug Discovery |  News | 0 Comment | 12 Feb, 2019

Merck and Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for BAVEN...Read more

Teva announces US launch of Vigabatrin

Drug Discovery |  News | 0 Comment | 08 Feb, 2019

Teva Pharmaceutical Industries has announced the launch of a generic version of Sabril®1 (vigabatrin) tablets, 500 mg in the US, the first generic version of Sabril® (viga...Read more

Perrigo to launch its AB rated generic Zovirax cream

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

Perrigo Company plc has announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Zovirax® Cream,...Read more

BioLineRx gets Orphan Drug Designation for its pancreatic cancer drug

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

BioLineRx Ltd., an Israeli clinical-stage biopharmaceutical company focused on oncology, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to it...Read more

Reaction Biology Corporation buys ProQinase GmbH

Drug Discovery |  News | 0 Comment | 05 Feb, 2019

Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange transaction through which RBC has acquired all the shares of ProQinase G...Read more

I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study

Drug Discovery |  News | 0 Comment | 04 Feb, 2019

I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune disease...Read more

FDA expands Lilly's ALIMTA Label

Drug Discovery |  News | 0 Comment | 01 Feb, 2019

Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed for injection) in combination with KEYTRUDA® (pembrolizumab...Read more

Neurocrine Biosciences collaborates with Voyager Therapeutics

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Neurocrine Biosciences and Voyager Therapeutics has announced the formation of a strategic collaboration focused on the development and commercialization of Voyager’s gene therapy pro...Read more

Pfizer and Lilly announce top-line results of Tanezumab

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis (OA) pain. As per ...Read more

J&J announces USFDA approval of IMBRUVICA

Drug Discovery |  News | 0 Comment | 29 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with obinu...Read more

Basilea announces collaboration with Roche

Drug Discovery |  News | 0 Comment | 25 Jan, 2019

Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche to explore a combination of Basilea's derazantinib and Roche's PD-L1-...Read more

Wren Therapeutics completes £18M Series A Financing

Drug Discovery |  News | 0 Comment | 23 Jan, 2019

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases has announced that it has completed a Series A financing round. The ...Read more